(R)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole

Catalog No. :
ACIXQY409
CAS No. :
2757083-00-2
Molecular Formula :
C12H16N2O
Molecular Weight :
204.27

IUPAC Name:(R)-4-isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole

(R)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$79.00Login to see priceIn stockIn stock
1g97%$303.00Login to see priceIn stockIn stock
5g97%$1470.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole
IUPAC Name(R)-4-isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole
MDL No.MFCD34596666
Molecular FormulaC12H16N2O
Molecular Weight204.27
SMILESCC1=CC=CC(C2=N[C@H](C(C)C)CO2)=N1
InChI KeyVMSCZASBHFNABE-NSHDSACASA-N
SynonymPyridine, 2-[(4R)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methyl-;(R)-4-Isopropyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole - [K91156]
CAS No.2757083-00-2
PubChem CID100993953

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACIXQY409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCYVO619 route compound structure diagram
    ACCYVO6195315-25-3 In Stock
  4. Then
  5. ACIXQY409 route product structure diagram
    ACIXQY4092757083-00-2 In Stock
Inquiry

2. ACIXQY409 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIXQY409 route product structure diagram
    ACIXQY4092757083-00-2 In Stock
Inquiry

Comments (0)